Back to top

ONO’s Tirabrutinib Liver Study Completion: What It Means for OPHLF Investors

ONO Pharmaceutical Co ($OPHLF) announced an update on their ongoing clinical study. ONO Pharmaceutical Co. (OPHLF) has completed a Phase 1 study ti...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ono Pharmaceutical Co. (OPHLF)